Navigation Links
Report: JDRF 2013 Annual Research Spending Down by $50 million
Date:7/25/2014

New York, New York (PRWEB) July 25, 2014

A report released by the Juvenile Diabetes Cure Alliance reviews JDRF’s revenue and spending during fiscal year 2013 (July 1, 2012- June 30, 2013).

Outside of the US government’s National Institutes of Health (NIH), the JDRF is the largest single funder of type 1 diabetes research in the world. It has global reach and relationships with most of the top research centers. There is no organization better positioned to deliver a cure for type 1 diabetes in the near future.

Since the 2008 financial crisis, revenue has been steadily increasing. The JDRF has well-honed fundraising operations, and a majority of their annual revenue comes from community building events such as walks and galas. “The JDRF is unique in that a majority of its revenues are generated by small gifts from many donors, rather than very large gifts from a few high net worth individuals,” Phil Shaw, General Manager of the JDCA, said. “Every donor’s voice and intentions matter, but it is even more true for an organization built on walkers, volunteers, and small donors.”

At its peak in 2008, type 1 research grants were 66% of total annual spending. In 2013, this decreased to only 51%; it’s lowest level in 10 years. Furthermore, spending on research grants dropped substantially from $156 million in 2008 to only $106 million in 2013. This is a decline of nearly 30% while all non-research categories increased.

“This trend away from research is worrying,” Shaw said. “We’ve found through regular surveys that the vast majority of donors give with the desire to support cure research. Donors need to be aware of this shift and urge the JDRF to reverse this spending that is not aligned with their priorities and not focused on delivering a cure in the near term.”

To download a copy of the report and explore more information on the major type 1 nonprofits, visit the JDCA website.

About the JDCA

The JDCA is an independent analyst of the type 1 diabetes charitable universe and brings a business-like perspective to help donors focus research toward a practical cure. The mission of the JDCA is to achieve a type 1 practical cure before 2025 by steering donor contributions to the most effective charities.

Become an Alliance member: http://bit.ly/JointheJDCA
Become a fan on Facebook: https://www.facebook.com/thejdca
Follow us on Twitter: https://twitter.com/JDCA2025

###

Read the full story at http://www.prweb.com/releases/2014/07/prweb12044231.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs
2. Special Occasion Dresses Trend Report: Affordable, High Quality Mother of the Bride Gowns and Flower Girl Dresses Unveiled at AngelWeddingDress.com
3. Register to Download Merrill DataSite's Report: Capitalizing on the Shifting Sands of the Energy Market
4. CDC report: Patients harmed after health-care providers steal patients drugs
5. Global Fermentation Chemicals Market Research Report: Transparency Market Research
6. FDAnews Management Report: Implementing Risk-Based Verification and Validation
7. EpiCast Report: Acute Ischemic Stroke - Epidemiology Forecast to 2022
8. EpiCast Report: Endometriosis - Epidemiology Forecast to 2022
9. Download the Merrill DataSite's Report: Best Practices of the Best Dealmakers
10. EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022
11. FDAnews Management Report: Managing Contract Manufacturers and Testing Labs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... IN (PRWEB) , ... May 03, 2016 , ... ... benefits advisory organization, announces Benefits Alliance Insurance Services as the latest addition to ... Southern California-based Firm comprised of Partners Wayne Blasman, David Styles, and Paul Vincent. ...
(Date:5/3/2016)... ... May 03, 2016 , ... For the sixth consecutive year, ... Technology (ICT) companies in the annual Branham300 listing. For 23 years, the Branhan300 ... ranked by revenue. , “We are honored to be on the Branham300 ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Dr. Poneh ... on cosmetic dental treatments to both new and existing patients. Cosmetic dentistry allows patients ... for patients who have healthy smiles with some minor or more serious cosmetic flaws. ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... availability of the latest release of DocAve 6 Service Pack (SP) 7, ... organizations migrate to SharePoint 2016 and take advantage of the platform’s latest features ...
(Date:5/3/2016)... , ... May 03, 2016 ... ... of Microsoft secure remote access connectivity solutions, today announced the new SecureAccess ... Microsoft DirectAccess. The new Celestix SecureAccess release will enable organizations to get ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... , May 3, 2016 ... Research Report provides a basic overview of the ... post which the surgical mesh report explores into ... Complete report on Surgical Mesh market ... and 98 tables and figures is available at ...
(Date:5/2/2016)... 2016  Deerfield announced today it led the ... Inc. Graybug Vision is an early stage pharmaceutical ... care for ocular diseases including wet age-related macular ... first developed at Johns Hopkins University and has ... Graybug Vision is developing ophthalmology products ...
Breaking Medicine Technology: